Jian-jiao Wang - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Medical Oncology (Northwood, London, England)|August 23, 2014

A sub-pathway based method to identify candidate drugs for glioblastomasYong-ri Zheng, Kai Kang, Jian-jiao Wang

Neuroscience Letters|May 18, 2011

WITHDRAWN: Discrimination of Parkinson-associated LRRK2 alleles by introduction of a single nucleotide mismatch into siRNAJian-Jiao Wang, Qing-Song Li, Yang Li, et al.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|September 16, 2022

[Association between neonatal discharge preparedness and adverse health events]Wen-Pei Cao, Gui-Rong Li, Yu Guo, et al.

Zhonghua Yi Xue Za Zhi|March 23, 2011

[Comparison of MGMT and ERCC₂ expression in temozolomide for the treatment of malignant glioma drug resistance and their genetic relationship]Xu Hou, Yan Zhao, Yong-Ri Zheng, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Medical Oncology (Northwood, London, England)|August 23, 2014

A sub-pathway based method to identify candidate drugs for glioblastomasYong-ri Zheng, Kai Kang, Jian-jiao Wang

Neuroscience Letters|May 18, 2011

WITHDRAWN: Discrimination of Parkinson-associated LRRK2 alleles by introduction of a single nucleotide mismatch into siRNAJian-Jiao Wang, Qing-Song Li, Yang Li, et al.

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|September 16, 2022

[Association between neonatal discharge preparedness and adverse health events]Wen-Pei Cao, Gui-Rong Li, Yu Guo, et al.

Zhonghua Yi Xue Za Zhi|March 23, 2011

[Comparison of MGMT and ERCC₂ expression in temozolomide for the treatment of malignant glioma drug resistance and their genetic relationship]Xu Hou, Yan Zhao, Yong-Ri Zheng, et al.

Pageof 1